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INTRODUCTION: 
Recently, it was reported that the heterocyclic moiety 
such as triazole based thiadiazoles and thiadiazines 
possess variety of pharmacological activities like 
antimicrobial 1 antiviral 2 antibacterial, 3 anti-
inflammatory, 4 herbicidal 5 and anti-HIV-1.6 On the 
other hand, it has been reported that certain compounds 
bearing a thiadiazole and 1,2,4-triazole nucleus possess 
significant anti-inflammatory activity. 7 
These initial reports stimulated us to integrate thiadiazine 
moiety in triazole frame work, since these systems 
possess well documented antimicrobial and nematicidal 
activity. The target compounds, 3-(1H-indole-4-yl)-6-
aryl-7H-[1,2,4]-triazolo-[3,4-b][1,3,4]-thiadiazines (6a-f) 
have been prepared by using commercially available 1H-
indole-4-carboxylic acid (1) as raw material and by 
involving 1H-indole-4-carboxylic acid ethyl ester (2), 
1H-indole-4-carboxylic acid hydrazide (3), 5-(1H-indole-
4-yl)-[1,3,4]oxadiazole-2-thiol (4) and 4-amino-5-(1H-
indol-4-yl)-4H-[1,2,4]-triazole-3-thiol (5) as 
intermediates. 
The initial intermediate, 1H-indole-4-carboxylic acid 
ethyl ester (2) has been prepared through esterification 
by boiling of a mixture of 1H-indole-4-carboxylic acid 
(1) and sulfuric acid in ethanol for 4 h. The compound 2 
was reacted with hydrazine hydrate in absolute ethyl 
alcohol at reflux for 8 h to get 1H-indole-4-carboxylic 
acid hydrazide (3). The intermediate, 5-(1H-indole-4-yl)-
[1,3,4]oxadiazole-2-thiol (4) for the synthesis of title 
compounds was prepared by the cyclization of 
compound 3 with carbon disulphide in the presence of 
potassium hydroxide in ethanol at reflux for 14 h 
followed by acidification. Further the compound 4 when 
reacted with hydrazine hydrate in ethanol at reflux for 6 
h resulted 4-amino-5-(1H-indol-4-yl)-4H-[1,2,4]triazole-
3-thiol (5). Finally, the compound 5 has been condensed 
successively with a variety of phenacylbromides in ethyl 
alcohol under reflux for 8-10 h to get the title 
compounds, 3-(1H-indole-4-yl)-6-aryl-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazines (6a-f). The chemical 
structures of the all newly synthesized compounds were 
elucidated by their IR, 1H and 13 C NMR, mass spectral 
data and elemental analysis. Further, the target 
compounds were used to find their antifungal and 
nematicidal activity. 
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Scheme 1: 6 Ar = (a) C6H5; (b) 4-OCH3C6H4; (c) 4-ClC6H4; (d) 4-BrC6H4; (e) 4-NO2C6H4; (f) 4-OHC6H4 
ABSTRACTS: 
A series of novel 3-(1H-indole-4-yl)-6-aryl-7H-[1,2,4]-triazolo-[3,4-b][1,3,4]-thiadiazines (6a-f) were synthesized by 
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triazole-3-thiol (5)as intermediates. The chemical structures of the all newly synthesized compounds were elucidated by their 
IR, 1H and 13 C NMR, mass spectral data and elemental analysis. Further, the target compounds were used to find their 
antifungal and nematicidal activity. 
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Table 1:  In vitro antifungal activity of compounds 6a-f (MIC in μg/mL) 
Compound     C. albicans     A. Fumigatus     T. Rubrum     T. Mentropyhte 
6a                     25.0                12.5                   >50.0                25.0 
6b                     25.0                25.0                     25.0                25.0 
6c                     12.5                6.25                     3.12                3.12 
6d                     25.0                12.5                     6.25                12.5 
6e                     3.12                12.5                     12.5                25.0 
6f                     50.0                 25.0                    12.5                12.5 
 Amphotericin B          6.25                   3.12                       3.12                   3.12 
 
Table 2: Median lethal dose (LD50, ppm) of compounds 6a-f 
                      Nematicide                  6a          6b         6c           6d             6e           6f        Levamisole 
                       D. myceliophagus       170        270       950         430           570         190        170 
                       C. elegans                   190        220       870         200           610         780        180 
 
ANTIFUNGAL ACTIVITY  
Compounds 6a-f were screened for their antifungal 
activity against four fungal organisms viz., Candida 
albicans, Aspergillus fumigatus, Trichophyton rubrum, 
and Trichophyton mentagrophytes in dimethyl sulfoxide 
by broth dilution method.[8] The minimum inhibitory 
concentration (MIC, µg/mL) were measured and 
compared with the standard drug Aamphotericin B 
(Table 1). Among the screened compounds, 6c is highly 
active against T. rubrum, T. mentagrophytes, 6e is also 
active against only C. albicans and 6g is highly active 
against C. albicans, T. mentagrophytes and the activity 
of these compounds are almost equal to the standard. All 
the compounds in this series exhibited either excellent or 
moderate activity towards different organisms. None of 
the compounds is inactive against any one of the 
organism. It is interesting to note that 6e showed 
excellent antifungal activity towards C. albicans at the 
concentration of 3.12 µg/mL, which is less than the 
concentration of the standard. 
NEMATICIDAL ACTIVITY  
All the newly synthesized compounds 6 a-f in this study 
were also assayed for their nematicidal activity against 
Ditylenchus myceliophagus and Caenorhabditis elegans 
by aqueous in vitro screening technique[9] at various 
concentrations. The results have been expressed in terms 
of LD50 i.e. median lethal dose at which 50% nematodes 
became immobile (dead), and compared with the 
standard drug levamisole. The screened data reveal that, 
6a is the most effective against D. myceliophagus and C. 
elegans with LD50 of 170 and 190 ppm, respectively.  
The compounds 6d and 6f are also most active against C. 
elegans with LD50 of 200 ppm and D. myceliophagus 
with LD50 of 190 ppm, respectively.  The activity of 6a is 
almost equal to the activity of the standard Levamisole. 
The other tested compounds showed moderate activity.  
The LD50 values of the compounds screened are 
presented in Table 2. 
EXPERIMENTAL 
All the reagents and solvents were used as purchased 
without further purification. Melting points were 
determined on a Fisher–Johns melting point apparatus 
and are uncorrected. IR spectra were obtained on a 
Perkin-Elmer BX serried FTIR 5000 spectrometer using 
KBr pellet. NMR spectra were recorded on a Varian 300 
MHz spectrometer for 1H–NMR and 100 MHz for 13C–
NMR. The chemical shifts were reported as ppm down 
field using TMS as an internal standard. Mass spectra 
were recorded on a VG-Micromass 7070H spectrometer 
operating at 70 eV.  
1H-Indole-4-carboxylic acid ethyl ester (2) To the 
solution of 1H-indole-4-carboxylic acid (1) (0.01 mol) in 
absolute ethyl alcohol (15 ml), conc. H2SO4 (2 ml) was 
added.  The mixture was refluxed for 4 h.  After 
completion of the reaction (monitored by TLC), the 
solvent was removed under reduced pressure and the 
obtained residue was recrystallized with petroleum ether 
to get pure 1H-indole-4-carboxylic acid ethyl ester (2). 
 
1H-Indole-4-carboxylic acid hydrazide (3) A mixture 
of 1H-indole-4-carboxylic acid ethyl ester (2) (0.01 mol) 
and hydrazine hydrate (0.025 mol) in ethanol (20 ml) 
was refluxed for 8 h. After completion of the reaction 
(monitored by TLC), the mixture was cooled to room 
temperature and filtered.  The crude product was 
recrystallized from ethanol to give 1H-indole-4-
carboxylic acid hydrazide (3) in pure form. 
5-(1H-Indole-4-yl)-[1,3,4]oxadiazole-2-thiol (4) A 
mixture of 1H-indole-4-carboxylic acid hydrazide (3) 
(0.01 mol), potassium hydroxide (0.02 mol) and carbon 
disulfide (0.03 mol) in ethanol (100 mL) was heated 
under reflux with stirring for 14 h. The solvent was 
distilled in vacuo, the residual mass was poured over 
crushed ice and neutralized the alkaline solution with 
10% hydrochloric acid.  The precipitated crude product 
was filtered, washed with water, dried and recrystallized 
from ethanol to get the pure compound 5-(1H-indole-4-
yl)-[1,3,4]oxadiazole-2-thiol (4).  
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4-Amino-5-(1H-indol-4-yl)-4H-[1,2,4]-triazole-3-thiol 
(5) To a warm solution of 5-(1H-indole-4-yl)-[1,3,4]-
oxadiazole-2-thiol (4) (0.01 mol) in ethanol (20 mL), 
80% hydrazine hydrate (0.03 mol) was added drop wise 
and the reaction mixture was heated under reflux for 7 h. 
The solvent was distilled off in vacuo, cooled and the 
solid separated were filtered, washed with cold ethanol 
and recrystallized from chloroform to give pure 
compound 4-amino-5-(1H-indol-4-yl)-4H-[1,2,4]-
triazole-3-thiol (5). 
3-(1H-indole-4-yl)-6-aryl-7H-[1,2,4]-triazolo-[3,4-
b][1,3,4]-thiadiazines (6a-f) A mixture of 4-amino-5-
(1H-indol-4-yl)-4H-[1,2,4]-triazole-3-thiol (5) (0.01 mol) 
and corresponding phenacylbromide (0.02 mol) in 
absolute ethanol (20 mL) was refluxed for 8–10 h.  The 
reaction mixture was concentrated and cooled to room 
temperature, and the remaining solvent was removed 
under reduced pressure, then diethyl ether (25 mL) was 
added and the reaction mixture was left at 0 oC for 
overnight. The precipitated solid was filtered off. The 
crude product thus obtained was purified by column 
chromatography on silica gel with hexane-ethyl acetate 
as eluent to afford pure 3-(1H-indole-4-yl)-6-aryl-7H-
[1,2,4]-triazolo-[3,4-b][1,3,4]-thiadiazines (6a-f). 
PHYSICAL AND SPECTRAL DATA 
 1H-Indole-4-carboxylic acid ethyl ester (2) Yellow 
solid; yield 78%; bp 342-343 °C; IR (KBr) cm–1: 3212 
(N-H), 3024 (Ar-H), 2962 (C-H, CH3), 1699(C=N), 1588 
(C=C); 1H-NMR (CDCl3) δ: 1.24 (3H, t, J = 5.6 Hz, 
CH3), 4.00 (2H, q, J = 5.6 Hz, CH2), 7.42 (1H, d, J = 7.4 
Hz, Ar-H), 7.39-7.62 (3H, m, Ar-H), 7.85 (1H, d, J = 7.4 
Hz, Ar-H), 11.12 (1H, s, NH); 13C-NMR (CDCl3) δ: 
13.6, 59.1, 106.3, 112.5, 119.4, 121.7, 122.8, 126.3, 
130.4, 132.5, 165.4; MS m/z: 189 (M+); Elemental 
analysis calculated for C11H11NO2: C-69.83, H-5.86, N-
7.40, O-16.91. Found: C-67.36, H-5.42, N-7.06, O-
15.98. 
1H-Indole-4-carboxylic acid hydrazide (3) Brown 
solid; yield 81%; mp 187-189 °C; IR (KBr) cm–1: 3318 
(NH2), 3218 (N-H), 3065 (Ar-H), 1645 (C=N), 1548 
(C=C); 1H-NMR (CDCl3) δ: 5.30 (2H, s, NH2), 7.38 (1H, 
d, J = 7.2 Hz, Ar-H), 7.42-7.64 (3H, m, Ar-H), 7.70 (1H, 
s, NH), 7.79 (1H, d, J = 7.2 Hz, Ar-H), 11.06 (1H, s, 
NH); 13C-NMR (CDCl3) δ: 105.7, 114.2, 121.0, 123.7, 
124.4, 127.3, 132.7, 135.3, 162.3; MS m/z: 175 (M+); 
Elemental analysis calculated for C9H9N3O: C-61.70, H-
5.18, N-23.99, O-9.13. Found: C-60.12, H-4.89, N-
22.17, O-8.89. 
5-(1H-Indole-4-yl)-[1,3,4]oxadiazole-2-thiol (4) Pale 
yellow solid; yield 74%; mp 185-187 °C; IR (KBr) cm–1: 
3236 (N-H), 3028 (Ar-H),  2610 (S-H), 1648 (C=N), 
1559 (C=C), 1155; 1H-NMR (CDCl3) δ: 3.81 (1H, s, 
SH), 7.35 (1H, d, J = 7.6 Hz, Ar-H), 7.41-7.58 (3H, m, 
Ar-H), 7.79 (1H, d, J = 7.6 Hz, Ar-H), 11.24 (1H, s, 
NH); 13C-NMR (CDCl3) δ: 102.4, 116.3, 120.7, 123.4, 
125.8, 128.4, 136.1, 139.8, 145.6, 158.9; MS m/z: 217 
(M+); Elemental analysis calculated for C10H7N3OS: C-
55.29, H-3.25, N-19.34, O-7.69, S-14.76. Found: C-
53.69, H-3.12, N-18.45, O-7.02, S-13.38. 
4-Amino-5-(1H-indol-4-yl)-4H-[1,2,4]-triazole-3-thiol 
(5) White solid; yield 72%; mp 147-149 °C; IR (KBr) 
cm–1: 3248 (N-H), 3018 (Ar-H), 2648 (S-H), 1662 
(C=N), 1552 (C=C); 1H-NMR (CDCl3) δ: 3.65 (1H, s, 
SH), 3.85 (2H, s, NH2), 7.37 (1H, d, J = 7.3 Hz, Ar-H), 
7.45-7.74 (3H, m, Ar-H), 7.80 (1H, d, J = 7.3 Hz, Ar-H), 
11.21 (1H, s, NH); 13C-NMR (CDCl3) δ: 105.6, 110.8, 
116.7, 119.4, 127.6, 129.4, 132.4, 137.6, 142.3, 152.7; 
MS m/z: 231 (M+); Elemental analysis calculated for 
C10H9N5S: C-51.93, H-3.92, N-30.28, S-13.86. Found: 
C-50.12, H-3.45, N-29.65, S-12.98. 
3-(1H-Indole-4-yl)-6-phenyl-7H-[1,2,4]-triazolo-[3,4-
b][1,3,4]-thiadiazine (6a) Pink solid; yield 75%; mp 
158-160 °C; IR (KBr) cm–1: 3245 (N-H), 3018 (Ar-H), 
2965 (C-H, CH2),  1638 (C=N), 1548 (C=C); 
1H-NMR 
(CDCl3) δ: 1.86 (2H, s, CH2), 7.32 (1H, d, J = 6.8 Hz, 
Ar-H), 7.41-7.74 (8H, m, Ar-H), 7.79 (1H, d, J = 6.8 Hz, 
Ar-H), 10.98 (1H, s, NH); 13C-NMR (CDCl3) δ: 33.7, 
104.3, 116.7, 121.0, 125.4, 126.3, 128.7 (2), 129.7, 
130.2, 131.7 (2), 132.7, 133.1, 138.4, 144.2, 148.7, 
162.3; MS m/z: 331 (M+); Elemental analysis calculated 
for C18H13N5S: C-65.24, H-3.95, N-21.13, S-9.68. 
Found: C-63.25, H-3.64, N-20.28, S-8.95. 
3-(1H-Indole-4-yl)-6-(4-methoxy-phenyl)-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazine (6b) Pink solid; yield 
80%; mp 162-164 °C; IR (KBr) cm–1: 3239 (N-H), 3024 
(Ar-H), 2960 (C-H, CH2), 1642 (C=N), 1568 (C=C), 
1145 (C-O); 1H-NMR (CDCl3) δ: 1.74 (2H, s, CH2), 1.24 
(3H, s, CH3), 7.29 (1H, d, J = 7.0 Hz, Ar-H), 7.32 (2H, d, 
J = 7.2 Hz, Ar-H), 7.40 (2H, d, J = 7.2 Hz, Ar-H), 7.42-
7.81 (3H, m, Ar-H), 7.85 (1H, d, J = 7.0 Hz, Ar-H), 
10.84 (1H, s, NH); 13C-NMR (CDCl3) δ: 30.3, 44.7, 
106.7, 118.4, 123.4, 126.3, 128.7, 129.6 (2), 130.7, 
132.7, 133.2 (2), 134.1, 135.2, 137.4, 146.7, 149.5, 
163.1; MS m/z: 361 (M+); Elemental analysis calculated 
for C19H15N5OS: C-63.14, H-4.18, N-19.38, O-4.43, S-
8.87. Found: C-61.23, H-3.84, N-18.28, O-4.12, S-7.84. 
3-(1H-Indole-4-yl)-6-(4-chloro-phenyl)-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazine (6c) Yellow solid; 
yield 82%; mp 126-128 °C; IR (KBr) cm–1: 3240 (N-H), 
3028 (Ar-H), 2958 (C-H, CH2), 1654 (C=N), 1595 
(C=C); 1H-NMR (CDCl3) δ: 1.68 (2H, s, CH2), 7.26 (1H, 
d, J = 7.4 Hz, Ar-H), 7.30 (2H, d, J = 7.0 Hz, Ar-H), 7.38 
(2H, d, J = 7.0 Hz, Ar-H), 7.46-7.76 (3H, m, Ar-H), 7.79 
(1H, d, J = 7.4 Hz, Ar-H), 10.92 (1H, s, NH); 13C-NMR 
(CDCl3) δ: 32.3, 104.2, 116.2, 119.7, 122.0, 124.2, 125.3 
(2), 128.4, 136.3, 139.2 (2), 140.2, 141.0, 142.7, 148.7, 
150.2, 165.7; MS m/z: 365 (M+); Elemental analysis 
calculated for C18H12ClN5S: C-59.09, H-3.31, Cl-9.69, 
N-19.14, S-8.76. Found: C-57.16, H-3.14, Cl-8.84, N-
18.56, S-7.48. 
3-(1H-Indole-4-yl)-6-(4-bromo-phenyl)-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazine (6d) Brown solid; 
yield 81%; mp 132-134 °C; IR (KBr) cm–1: 3258 (N-H), 
3032 (Ar-H), 2962 (C-H, CH2), 1664 (C=N), 1565 
(C=C); 1H-NMR (CDCl3) δ: 1.54 (2H, s, CH2), 7.16 (1H, 
d, J = 7.3 Hz, Ar-H), 7.26 (2H, d, J = 7.3 Hz, Ar-H), 7.34 
(2H, d, J = 7.5 Hz, Ar-H), 7.40-7.68 (3H, m, Ar-H), 7.72 
(1H, d, J = 7.5 Hz, Ar-H), 10.86 (1H, s, NH); 13C-NMR 
(CDCl3) δ: 36.3, 107.4, 112.0, 115.7, 118.6, 120.8, 122.3 
(2), 124.7, 132.6, 134.8 (2), 138.7, 140.2, 145.7, 146.3, 
152.7, 163.8; MS m/z: 410 (M+); Elemental analysis 
calculated for C18H12BrN5S: C-52.69, H-2.95, Br-19.47, 
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N-17.07, S-7.89. Found: C-50.36, H-2.65, Br-18.84, N-
16.47, S-9.89. 
3-(1H-Indole-4-yl)-6-(4-nitro-phenyl)-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazine (6e) White solid; 
yield 79%; mp 154-156 °C; IR (KBr) cm–1: 3262 (N-H), 
3027 (Ar-H), 2945 (C-H, CH2), 1652 (C=N), 1556 
(C=C); 1H-NMR (CDCl3) δ: 1.58 (2H, s, CH2), 7.26 (1H, 
d, J = 6.8 Hz, Ar-H), 7.31 (2H, d, J = 6.8 Hz, Ar-H), 7.38 
(2H, d, J = 7.2 Hz, Ar-H), 7.45-7.72 (3H, m, Ar-H), 7.78 
(1H, d, J = 7.2 Hz, Ar-H), 11.08 (1H, s, NH); 13C-NMR 
(CDCl3) δ: 33.7, 108.9, 114.7, 117.4, 119.6, 122.3, 124.7 
(2), 126.8, 133.7, 135.8 (2), 139.7, 142.4, 148.7, 149.6, 
153.7, 164.9; MS m/z: 376 (M+); Elemental analysis 
calculated for C18H12N6O2S: C-57.44, H-3.21, N-22.33, 
O-8.50, S-8.52. Found: C-55.98, H-3.12, N-21.28, O-
7.87, S-7.95. 
3-(1H-Indole-4-yl)-6-(4-hydroxy-phenyl)-7H-[1,2,4]-
triazolo-[3,4-b][1,3,4]-thiadiazine (6f) Pale  solid; yield 
77%; mp 139-141 °C; IR (KBr) cm–1: 3256 (N-H), 3042 
(Ar-H), 2938 (C-H, CH2), 1665 (C=N), 1548 (C=C); 
1H-
NMR (CDCl3) δ: 1.46 (2H, s, CH2), 5.02 (1H, s, OH), 
7.22 (1H, d, J = 7.0 Hz, Ar-H), 7.35 (2H, d, J = 7.0 Hz, 
Ar-H), 7.40 (2H, d, J = 7.4 Hz, Ar-H), 7.48-7.78 (3H, m, 
Ar-H), 7.84 (1H, d, J = 7.4 Hz, Ar-H), 11.10 (1H, s, 
NH); 13C-NMR (CDCl3) δ: 30.3, 112.8, 115.4, 116.3, 
121.4, 123.7, 126.8 (2), 128.7, 135.7, 138.7 (2), 140.2, 
143.6, 145.7, 147.8, 151.6, 165.6; MS m/z: 347 (M+); 
Elemental analysis calculated for C18H13N5OS: C-62.23, 
H-3.77, N-20.16, O-4.61, S-9.23. Found: C-60.54, H-
3.42, N-19.65, O-4.21, S-8.85. 
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